Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 17 04:00PM ET
127.64
Dollar change
0.00
Percentage change
0.00
%
IndexS&P 500 P/E17.23 EPS (ttm)7.41 Insider Own1.67% Shs Outstand88.82M Perf Week-3.35%
Market Cap11.19B Forward P/E12.21 EPS next Y10.46 Insider Trans-8.84% Shs Float86.23M Perf Month-6.85%
Income691.53M PEG1.15 EPS next Q1.95 Inst Own91.98% Short Float4.80% Perf Quarter21.97%
Sales12.14B P/S0.92 EPS this Y9.81% Inst Trans-2.64% Short Ratio4.93 Perf Half Y71.17%
Book/sh11.89 P/B10.74 EPS next Y12.42% ROA3.92% Short Interest4.14M Perf Year52.21%
Cash/sh5.43 P/C23.51 EPS next 5Y15.00% ROE78.21% 52W Range71.51 - 141.54 Perf YTD21.84%
Dividend Est.- P/FCF7.48 EPS past 5Y51.82% ROI5.93% 52W High-9.82% Beta1.06
Dividend TTM- Quick Ratio1.13 Sales past 5Y1.27% Gross Margin25.33% 52W Low78.49% ATR (14)2.85
Dividend Ex-Date- Current Ratio1.19 EPS Y/Y TTM30.63% Oper. Margin13.19% RSI (14)36.73 Volatility2.09% 1.83%
Employees70000 Debt/Eq10.53 Sales Y/Y TTM4.57% Profit Margin5.70% Recom3.00 Target Price131.66
Option/ShortYes / Yes LT Debt/Eq10.04 EPS Q/Q173.11% Payout0.00% Rel Volume0.00 Prev Close127.64
Sales Surprise4.57% EPS Surprise14.73% Sales Q/Q7.85% EarningsMay 02 AMC Avg Volume839.62K Price127.64
SMA20-4.67% SMA50-1.27% SMA20019.92% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Initiated Barclays Equal Weight $133
Aug-07-23Upgrade UBS Neutral → Buy $100 → $142
Nov-01-22Downgrade Deutsche Bank Buy → Hold $97 → $72
Oct-31-22Downgrade UBS Buy → Neutral $117 → $74
Aug-19-22Resumed UBS Buy $106 → $117
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Apr-17-24 07:31PM
Apr-12-24 05:50PM
Apr-10-24 01:35PM
09:40AM
09:00AM
09:00AM Loading…
09:00AM
Apr-08-24 06:00PM
Apr-02-24 09:40AM
Mar-25-24 10:59AM
10:46AM
09:40AM
Mar-24-24 05:49AM
Mar-22-24 09:52AM
Mar-21-24 12:00PM
Mar-19-24 05:10AM
09:40AM Loading…
Mar-15-24 09:40AM
Mar-14-24 11:30AM
Mar-11-24 04:40PM
Mar-08-24 05:20PM
09:40AM
05:44AM
Mar-06-24 10:09AM
09:49AM
09:15AM
Mar-05-24 04:50PM
04:19PM
03:34PM
10:08AM
09:00AM
Feb-29-24 07:19PM
11:23PM Loading…
Feb-28-24 11:23PM
Feb-27-24 07:47AM
Feb-23-24 12:00PM
Feb-22-24 10:31AM
09:50AM
Feb-21-24 12:20PM
09:40AM
Feb-20-24 01:53AM
Feb-15-24 09:15AM
08:50AM
12:22AM
Feb-14-24 07:08PM
11:44AM
09:10AM
Feb-13-24 08:14PM
08:00PM
05:20PM
04:50PM
04:36PM
04:08PM
Feb-12-24 06:02AM
Feb-09-24 10:51AM
06:15AM
Feb-01-24 09:40AM
Jan-31-24 03:55PM
Jan-23-24 02:00PM
Jan-22-24 09:50AM
Jan-19-24 09:40AM
Jan-16-24 09:40AM
Dec-30-23 09:26AM
04:30AM
Dec-29-23 12:34PM
Dec-26-23 09:59AM
Dec-25-23 09:40AM
Dec-19-23 10:00AM
Dec-08-23 09:40AM
Dec-07-23 11:31AM
Nov-30-23 10:00AM
Nov-28-23 06:30AM
04:03AM
Nov-27-23 11:20AM
09:07AM
Nov-22-23 10:40AM
09:40AM
Nov-15-23 11:54PM
Nov-13-23 09:31AM
Nov-10-23 12:00PM
Nov-09-23 09:55AM
Nov-08-23 05:46PM
12:22PM
10:56AM
07:27AM
01:33AM
Nov-07-23 10:07PM
08:30PM
04:44PM
04:40PM
04:05PM
09:40AM
Nov-06-23 09:40AM
Nov-03-23 12:21PM
Nov-02-23 12:05PM
Oct-25-23 12:33PM
Oct-24-23 07:00AM
Oct-23-23 10:15AM
09:40AM
08:00AM
Oct-20-23 09:40AM
Oct-18-23 04:52PM
12:00PM
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMar 13 '24Option Exercise52.4150,0002,620,500102,748Mar 15 06:13 PM
Rodriguez JavierChief Executive OfficerMar 06 '24Option Exercise67.80750,00050,850,0001,244,480Mar 08 05:04 PM
ACKERMAN JOELCFO and TreasuerMar 06 '24Option Exercise52.4155,0002,882,550195,360Mar 08 05:04 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMar 06 '24Option Exercise52.4150,0002,620,50087,687Mar 08 05:05 PM
Rodriguez JavierChief Executive OfficerFeb 28 '24Option Exercise67.8050,0003,390,000531,300Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 27 '24Sale126.877,397938,467481,300Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 26 '24Option Exercise67.80450,00030,510,000889,002Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 26 '24Sale126.1167,6038,525,130488,697Feb 28 05:51 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCFeb 21 '24Option Exercise52.41100,0005,241,000137,687Feb 23 05:44 PM
ACKERMAN JOELCFO and TreasuerFeb 21 '24Option Exercise52.4155,0002,882,550178,726Feb 23 05:43 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 21 '24Option Exercise52.4140,0002,096,400121,297Feb 23 05:44 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCFeb 21 '24Sale119.8129,4883,533,02537,687Feb 23 05:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 21 '24Sale120.7311,2851,362,43881,297Feb 23 05:44 PM
HEARTY JAMES OChief Compliance OfficerFeb 16 '24Option Exercise54.4054,6082,970,47878,448Feb 20 08:37 PM
HEARTY JAMES OChief Compliance OfficerFeb 16 '24Sale119.6426,1643,130,26920,264Feb 20 08:37 PM
Rodriguez JavierChief Executive OfficerDec 14 '23Option Exercise67.80500,00033,900,000833,299Dec 18 06:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 22 '23Option Exercise52.4140,0002,096,400121,297Aug 24 06:54 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 22 '23Sale101.819,794997,09981,297Aug 24 06:54 PM
YALE PHYLLIS RDirectorMay 12 '23Option Exercise66.297,165474,96820,275May 12 09:31 PM
YALE PHYLLIS RDirectorMay 12 '23Sale95.262,196209,19513,110May 12 09:31 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMay 10 '23Option Exercise66.29243,99416,174,362348,071May 12 09:34 PM
Rodriguez JavierChief Executive OfficerMay 10 '23Option Exercise66.2988,2135,847,640403,835May 12 09:20 PM
ACKERMAN JOELCFO and TreasuerMay 10 '23Option Exercise66.2956,3063,732,525191,097May 12 08:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffMay 10 '23Option Exercise66.2933,7842,239,541135,164May 12 09:15 PM
HEARTY JAMES OChief Compliance OfficerMay 10 '23Option Exercise66.2926,2761,741,83658,835May 12 08:48 PM
DESOER BARBARA JDirectorMay 10 '23Option Exercise66.297,165474,9687,165May 12 08:46 PM
NEHRA JOHN MDirectorMay 10 '23Option Exercise66.297,165474,9687,165May 12 08:50 PM
Rodriguez JavierChief Executive OfficerMay 10 '23Sale99.4416,9161,682,089315,622May 12 09:20 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffMay 10 '23Sale99.2415,9411,581,99091,245May 12 09:15 PM
HEARTY JAMES OChief Compliance OfficerMay 10 '23Sale101.645,745583,91432,559May 12 08:48 PM
DESOER BARBARA JDirectorMay 10 '23Sale101.612,449248,8430May 12 08:46 PM